Pharma Journalist -

Debiopharm International SA and ImmunoGen announced that Debiopharm has acquired ImmunoGen's IMGN529/Debio 1562, a clinical-stage anti-CD37 ADC (antibody-drug conjugates) for the…
Read More...

Palladio Biosciences announced that it has acquired global rights to lixivaptan from Chiesi USA to  develop it for Polycystic Kidney Disease (PKD), an orphan kidney disease for which…
Read More...

CROS NT announced an extension of its partnership with Medidata to provide customers with Medidata’s next-gen EDC and RTSM systems. Under the partnership, CROS NT will offer its…
Read More...

Worldwide Clinical Trials has appointed Karen Nowatkoski as Vice President of Clinical Operations and Site Management. She will oversee and provide global management for the team of…
Read More...

Tekni-Plex announced that it has acquired the assets of BrunaSeals which will become part of Tri-Seal, Tekni-Plex’s global closure liners business unit. Tri-Seal senior VP and…
Read More...

AstraZeneca announced that it has signed an agreement with Recordati for the commercial rights of Seloken/Seloken ZOK and associated Logimax fixed-dose combination treatments in Europe.…
Read More...

Nektar Therapeutics announced that Takeda signed the research collaboration agreement with Nektar Therapeutics through its wholly-owned subsidiary, Millennium Pharmaceuticals to enter…
Read More...

PCI Biotech and RXi Pharmaceuticals announced that they are extending their preclinical research collaboration initiated on April 7, 2015. The preclinical research collaboration will…
Read More...

EMA (European Medicines Agency) has recommended to grant a marketing authorisation in the European Union (EU) for a new ATMP (advanced therapy medicinal product) to treat adult patients…
Read More...

The EMA (European Medicines Agency) has recommended grant for marketing authorisation in the European Union (EU) for Oxervate (cenegermin) to treat neurotrophic keratitis. Oxervate is a…
Read More...